These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2751284)

  • 1. Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers.
    Lander RD; Henderson RP; Pyszczynski DR
    Antimicrob Agents Chemother; 1989 May; 33(5):710-3. PubMed ID: 2751284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-dose pharmacokinetics of piperacillin and azlocillin in 12 healthy volunteers.
    Tartaglione TA; Nye L; Vishniavsky N; Poynor W; Polk RE
    Clin Pharm; 1986 Nov; 5(11):911-6. PubMed ID: 3780161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of azlocillin in human chondral tissue.
    Schönfeld W; Knöller J; Bremm KD; Meier H; König W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):537-40. PubMed ID: 3381602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
    Wenzler E; Bleasdale SC; Sikka M; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA;
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.
    Colaizzi PA; Polk RE; Poynor WJ; Raffalovich AC; Cefali EA; Beightol LA
    Antimicrob Agents Chemother; 1986 May; 29(5):938-40. PubMed ID: 3729353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel therapeutic implications of azlocillin's dose-dependent pharmacokinetics: contributing physiologic mechanisms and a prospective, cross-over designed trial.
    Whelton A; Stout RL; Spilman PS; Delgado FA; Watson AJ
    J Clin Pharmacol; 1987 Jul; 27(7):491-8. PubMed ID: 3655000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of azlocillin in critical conditions: an individualized schedule of drug administration in relation to anatomo-physiologic and pathologic factors].
    Firsov AA; Nasonov VN; Mura'veva SA; Kruglov AA
    Antibiot Khimioter; 1989 Aug; 34(8):620-4. PubMed ID: 2589904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of high-dose azlocillin sodium in patients with cystic fibrosis.
    Woolf RA; Koup JR; Smith AL; Hilman BC; Goldmann D; Williams-Warren J
    Clin Pharm; 1985; 4(6):664-9. PubMed ID: 4075734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefepime in patients with thermal burn injury.
    Bonapace CR; White RL; Friedrich LV; Norcross ED; Bosso JA
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2848-54. PubMed ID: 10582870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin.
    Barriere SL; Catlin DH; Orlando PL; Noe A; Frost RW
    Antimicrob Agents Chemother; 1990 May; 34(5):823-6. PubMed ID: 2360821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.
    Reitberg DP; Whall TJ; Chung M; Blickens D; Swarz H; Arnold J
    Antimicrob Agents Chemother; 1988 Jan; 32(1):42-6. PubMed ID: 3348612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies.
    Delgado FA; Stout RL; Whelton A
    J Antimicrob Chemother; 1983 May; 11 Suppl B():79-88. PubMed ID: 6619035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S184-90. PubMed ID: 7152688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers.
    Healy DP; Polk RE; Garson ML; Rock DT; Comstock TJ
    Antimicrob Agents Chemother; 1987 Mar; 31(3):393-7. PubMed ID: 3579256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of continuous arteriovenous hemofiltration on the pharmacokinetics of azlocillin in anuric patients].
    Krupp A; Leuwer M; Schmidt H; Eberhardt B
    Anaesthesist; 1990 May; 39(5):275-8. PubMed ID: 2192573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacokinetics of azlocillin after single and multiple intravenous injections during the third trimester].
    Voigt R; Weidt I; Schröder S; Brandstädt A; Peiker G
    Zentralbl Gynakol; 1988; 110(15):944-8. PubMed ID: 3055753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic studies of azlocillin in pregnancy].
    Voigt R; Patsch R; Schröder S; Peiker G; Brandstädt A
    Z Geburtshilfe Perinatol; 1985; 189(2):88-90. PubMed ID: 4013451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.